4
Changes in Ownership
abrdn Life Sciences Investors Filed Acc 0001510281-24-000322
10% owner bought 13,361 shares at an average $13.78 ($184,081)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Saba Capital Management, L.P. 10% owner | 2024-06-06 | Purchase | +9,598 | $13.80 | $132,452 | 3,389,706 | I |
| Saba Capital Management, L.P. 10% owner | 2024-06-07 | Purchase | +3,763 | $13.72 | $51,628 | 3,393,469 | I |
| Open-market purchases · 13,361 sh · avg $13.78 · $184,081 | |||||||
Loading xslF345X05/primary_doc.xml…